Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Countries Contributing to Clinical Trials in Asia-Pacific 8 Top Five Countries Contributing to Clinical Trials in Europe 9 Top Countries Contributing to Clinical Trials in North America 10 Top Countries Contributing to Clinical Trials in Middle East and Africa 11 Clinical Trials by G7 Countries: Proportion of Narcolepsy to Central Nervous System Clinical Trials 12 Clinical Trials by Phase in G7 Countries 13 Clinical Trials in G7 Countries by Trial Status 14 Clinical Trials by E7 Countries: Proportion of Narcolepsy to Central Nervous System Clinical Trials 15 Clinical Trials by Phase in E7 Countries 16 Clinical Trials by Phase 17 In Progress Trials by Phase 18 Clinical Trials by Trial Status 19 Clinical Trials by End Point Status 20 Subjects Recruited Over a Period of Time 21 Clinical Trials by Sponsor Type 22 Prominent Sponsors 23 Top Companies Participating in Narcolepsy Therapeutics Clinical Trials 24 Prominent Drugs 26 Latest Clinical Trials News on Narcolepsy 27 Mar 31, 2016: Flamel Technologies Files Special Protocol Assessment for Once Nightly Sodium Oxybate 27 Mar 30, 2016: Theranexus: Preclinical Results Published in the Specialist Medical Journal Sleep 27 Clinical Trial Profile Snapshots 28 Appendix 68 Abbreviations 68 Definitions 68 Research Methodology 69 Secondary Research 69 About GlobalData 70 Contact Us 70 Disclaimer 70 Source 71

List of Tables Narcolepsy Therapeutics, Global, Clinical Trials by Region, 2016* 5 Narcolepsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Narcolepsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Narcolepsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8 Narcolepsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9 Narcolepsy Therapeutics Clinical Trials, North America, Top Countries, 2016* 10 Narcolepsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11 Proportion of Narcolepsy to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 12 Narcolepsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13 Narcolepsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14 Proportion of Narcolepsy to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 15 Narcolepsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16 Narcolepsy Therapeutics, Global, Clinical Trials by Phase, 2016* 17 Narcolepsy Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18 Narcolepsy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Narcolepsy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Narcolepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Narcolepsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22 Narcolepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Narcolepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25 Narcolepsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26 List of Figures Narcolepsy Therapeutics, Global, Clinical Trials by Region (%), 2016* 5 Narcolepsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Narcolepsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Narcolepsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8 Narcolepsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9 Narcolepsy Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10 Proportion of Narcolepsy to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 12 Narcolepsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13 Narcolepsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14 Proportion of Narcolepsy to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 15 Narcolepsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16 Narcolepsy Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17 Narcolepsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18 Narcolepsy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Narcolepsy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Narcolepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Narcolepsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22 Narcolepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Narcolepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24 Narcolepsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26 GlobalData Methodology 69

Jazz Pharmaceuticals Plc Teva Pharmaceutical Industries Ltd. Bioprojet SCR SK Holdings Co., Ltd. Flamel Technologies S.A. Concert Pharmaceuticals, Inc. Radiant Research, Inc. Altasciences Company Inc Aerial BioPharma LLC Clinilabs Inc.